Free Trial

Theravance Biopharma (TBPH) SEC Filings & 10K Form

Theravance Biopharma logo
$9.47 -0.14 (-1.46%)
(As of 11/22/2024 ET)

Recent Theravance Biopharma SEC Filings

DateFilerForm TypeView
11/22/2024
5:04 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:06 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:08 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:09 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:10 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:08 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:53 AM
Madison Avenue Partners, LP (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
11/14/2024
5:06 AM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
7:42 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
2:33 PM
Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
1:10 PM
Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/24/2024
3:44 PM
BlackRock, Inc. (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
09/23/2024
5:05 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
5:02 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:42 PM
BAUPOST GROUP LLC/MA (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
08/22/2024
7:03 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:05 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:06 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:07 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:09 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
5:02 PM
Samaha Eli (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
5:05 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:57 PM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/12/2024
5:15 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:02 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:04 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:06 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:08 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:10 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
5:01 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
5:26 AM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
5:01 PM
Smaldone Alsup Laurie (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:02 PM
BROSHY ERAN (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:04 PM
Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:06 PM
GRAY SUSANNAH (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:09 PM
MITCHELL DEAN J (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:10 PM
O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:12 PM
PAKIANATHAN DEEPIKA (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
3:15 PM
Theravance Biopharma (Filer)
Form DEF 14A
04/04/2024
5:09 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:11 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
New post-election stock warning from Wall Street (Ad)

If you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first time in history...

Not everything is as rosy as it seems on Wall Street.
04/04/2024
5:13 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:15 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:17 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:06 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
8:01 AM
Theravance Biopharma (Subject)
Weiss Asset Management LP (Filed by)
Form SC 13D/A
02/22/2024
7:04 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:06 PM
GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:08 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:10 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:11 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:14 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
7:12 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/16/2024
5:16 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
5:07 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
5:01 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
5:06 PM
Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/26/2023
5:09 PM
Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
4:10 PM
Theravance Biopharma (Filer)
Form DEFA14A
12/21/2023
4:06 PM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TBPH) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners